In vitro activity of 79 antimicrobial agents against Corynebacterium group D2
Open Access
- 1 October 1991
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (10) , 2140-2143
- https://doi.org/10.1128/aac.35.10.2140
Abstract
Corynebacterium group D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a number of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. beta-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.Keywords
This publication has 9 references indexed in Scilit:
- In vitro susceptibility ofCorynebacterium group D2 andCorynebacterium jeikeium to twelve antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Increasing incidence ofCorynebacterium group D2 strains resistant to norfloxacin and ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].1988
- Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240)European Journal of Clinical Microbiology & Infectious Diseases, 1988
- Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acidJournal of Antimicrobial Chemotherapy, 1987
- Bacteriuria with a Multiply Resistant Species of Corynebacterium (Corynebacterium Group D2): An Unnoticed Cause of Urinary Tract InfectionThe Journal of Infectious Diseases, 1987
- Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skinAntimicrobial Agents and Chemotherapy, 1987
- Antimicrobial susceptibility of Corynebacterium group D2Antimicrobial Agents and Chemotherapy, 1985